Fabio
9.0 KiB
9.0 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Prescription drugs; price transparency, definitions. | Prescription drug price transparency. Requires every health carrier, pharmacy benefits manager, wholesale drug distributer, and drug manufacturer to report information about prescription drug prices to the Department of Health and requires the Department to make such information available on its website. The bill also provides that, beginning January 1, 2022, a health plan enrollee's defined cost sharing for each prescription drug shall be calculated at the point of sale based on a price that is reduced by an amount equal to at least 80 percent of all rebates received, or to be received, in connection with the dispensing or administration of the prescription drug. The bill also requires the Bureau of Insurance to (i) identify all statutory and regulatory provisions from which health plans subject to the Employee Retirement Income Security Act of 1974 (ERISA) are exempted and (ii) determine the financial impact, if any, of application of such statutory and regulatory provisions such health plans, and to report its finding to the Chairman of the House Committees on Health, Welfare and Institutions and Labor and Commerce and the Chairmen of the Senate Committees on Commerce and Labor and Education and Health by October 1, 2021 | us/states/va | Virginia General Assembly | 2021 | HB 2007 | Virginia HB 2007 (2021) |
|
enacted |
|
5 | 47 | 11 | 2021-01-11 | 2021-03-24 | openstates | ocd-bill/7cbcf7a2-d28a-4c23-b4da-502ab9c7c2a7 | https://lis.virginia.gov/cgi-bin/legp604.exe?212+sum+HB2007 | a545a1ed20cb73937e448f5246c69ac614161706bb46ff0dd613eed7b6a57578 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 2007 (2021) — Prescription drugs; price transparency, definitions.
Prescription drug price transparency. Requires every health carrier, pharmacy benefits manager, wholesale drug distributer, and drug manufacturer to report information about prescription drug prices to the Department of Health and requires the Department to make such information available on its website. The bill also provides that, beginning January 1, 2022, a health plan enrollee's defined cost sharing for each prescription drug shall be calculated at the point of sale based on a price that is reduced by an amount equal to at least 80 percent of all rebates received, or to be received, in connection with the dispensing or administration of the prescription drug. The bill also requires the Bureau of Insurance to (i) identify all statutory and regulatory provisions from which health plans subject to the Employee Retirement Income Security Act of 1974 (ERISA) are exempted and (ii) determine the financial impact, if any, of application of such statutory and regulatory provisions such health plans, and to report its finding to the Chairman of the House Committees on Health, Welfare and Institutions and Labor and Commerce and the Chairmen of the Senate Committees on Commerce and Labor and Education and Health by October 1, 2021
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0304 (committee substitute) — source
- Committee substitute printed 21103917D-H1 (committee substitute) — source
- HB2007EH1 (committee substitute) — source
- HB2007ER (committee substitute) — source
- Prefiled and ordered printed; offered 01/13/21 21100752D (committee substitute) — source
Votes
- Reported from Education and Health with amendment (15-Y 0-N) — 15–0 (pass) · upper
- Reported from Finance and Appropriations (15-Y 0-N) — 15–0 (pass) · upper
- Passed Senate with amendment (39-Y 0-N) — 39–0 (pass) · upper
- Continued to 2021 Sp. Sess. 1 in Education and Health (15-Y 0-N) — 15–0 (pass) · upper
- Subcommittee recommends reporting with substitute (7-Y 1-N) — 7–1 (pass) · lower
- VOTE: Adoption (96-Y 1-N) — 95–1 (pass) · lower
- Subcommittee recommends reporting with amendments (8-Y 0-N) — 8–0 (pass) · lower
- Reported from Health, Welfare and Institutions with substitute (21-Y 1-N) — 21–1 (pass) · lower
- Reported from Appropriations with amendment(s) (22-Y 0-N) — 22–0 (pass) · lower
- VOTE: Passage (97-Y 1-N) — 96–1 (pass) · lower
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
Sponsors
- Mark D. Sickles — primary (person)
- Elizabeth R. Guzman — cosponsor (person)
- Hala S. Ayala — cosponsor (person)
- Hyland F. "Buddy" Fowler, Jr. — cosponsor (person)
- Kathleen Murphy — cosponsor (person)
- Kathy K.L. Tran — cosponsor (person)
- Marcia S. "Cia" Price — cosponsor (person)
- Mark H. Levine — cosponsor (person)
- Mark L. Keam — cosponsor (person)
- Rodney T. Willett — cosponsor (person)
- Scott A. Surovell — cosponsor (person)
- Suhas Subramanyam — cosponsor (person)
- Wendy W. Gooditis — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-01-11 Prefiled and ordered printed; offered 01/13/21 21100752D
introduction - 2021-01-11 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2021-01-22 Impact statement from DPB (HB2007)
- 2021-01-23 Assigned HWI sub: Health
referral-committee - 2021-01-26 Subcommittee recommends reporting with substitute (7-Y 1-N)
- 2021-01-28 House committee, floor amendments and substitutes offered
- 2021-01-28 Reported from Health, Welfare and Institutions with substitute (21-Y 1-N)
committee-passage - 2021-01-28 Committee substitute printed 21103917D-H1
substitution - 2021-01-28 Referred to Committee on Appropriations
referral-committee - 2021-01-28 Assigned App. sub: Health & Human Resources
referral-committee - 2021-01-29 Subcommittee recommends reporting with amendments (8-Y 0-N)
- 2021-01-29 House subcommittee amendments and substitutes offered
- 2021-01-29 Reported from Appropriations with amendment(s) (22-Y 0-N)
committee-passage - 2021-02-01 Impact statement from DPB (HB2007H1)
- 2021-02-01 Read first time
reading-1 - 2021-02-02 Read second time
reading-2 - 2021-02-02 Committee on Health, Welfare and Institutions substitute agreed to 21103917D-H1
- 2021-02-02 Committee on Appropriations amendments agreed to
- 2021-02-02 Engrossed by House - committee substitute with amendments HB2007EH1
- 2021-02-02 Printed as engrossed 21103917D-EH1
- 2021-02-03 Read third time and passed House (97-Y 1-N)
passage, reading-3 - 2021-02-03 VOTE: Passage (97-Y 1-N)
- 2021-02-04 Constitutional reading dispensed
- 2021-02-04 Referred to Committee on Education and Health
referral-committee - 2021-02-04 Impact statement from DPB (HB2007EH1)
- 2021-02-05 Continued to 2021 Sp. Sess. 1 in Education and Health (15-Y 0-N)
- 2021-02-12 Assigned Education sub: Health
referral-committee - 2021-02-16 Senate subcommittee amendments and substitutes offered
- 2021-02-18 Reported from Education and Health with amendment (15-Y 0-N)
committee-passage - 2021-02-18 Rereferred to Finance and Appropriations
referral-committee - 2021-02-22 Reported from Finance and Appropriations (15-Y 0-N)
committee-passage - 2021-02-24 Constitutional reading dispensed (39-Y 0-N)
- 2021-02-25 Read third time
reading-3 - 2021-02-25 Reading of amendment waived
- 2021-02-25 Committee amendment agreed to
- 2021-02-25 Engrossed by Senate as amended
- 2021-02-25 Passed Senate with amendment (39-Y 0-N)
passage - 2021-02-25 Placed on Calendar
- 2021-02-25 Senate amendment agreed to by House (96-Y 1-N)
- 2021-02-25 VOTE: Adoption (96-Y 1-N)
- 2021-03-09 Enrolled
- 2021-03-09 Impact statement from DPB (HB2007ER)
- 2021-03-09 Signed by President
- 2021-03-11 Signed by Speaker
- 2021-03-15 Enrolled Bill communicated to Governor on March 15, 2021
- 2021-03-15 Governor's Action Deadline 11:59 p.m., March 31, 2021
- 2021-03-24 Approved by Governor-Chapter 304 (effective - 1/1/22)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/7cbcf7a2-d28a-4c23-b4da-502ab9c7c2a7. Confidence: reported (aggregated from official Virginia legislature records).